The National Institute of Nursing Research is offering a grant for research examining the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life. This grant aims to stimulate understanding and improve care for individuals facing terminal illness. Deadline for applications is January 7, 2022.
Opportunity ID: 310032
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-19-045 |
Funding Opportunity Title: | End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.361 — Nursing Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 31, 2018 |
Last Updated Date: | Oct 31, 2018 |
Original Closing Date for Applications: | Jan 07, 2022 |
Current Closing Date for Applications: | Jan 07, 2022 |
Archive Date: | Feb 12, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Native American tribal governments (Federally recognized) Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public housing authorities/Indian housing authorities Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences and management of complex, advanced signs and symptoms at the end of life. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00245999 | Jan 05, 2019 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259408 | Jan 05, 2019 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269684 | Oct 28, 2021 | Jan 07, 2022 | View |
Package 1
Mandatory forms
310032 RR_SF424_2_0-2.0.pdf
310032 PHS398_CoverPageSupplement_4_0-4.0.pdf
310032 RR_OtherProjectInfo_1_4-1.4.pdf
310032 PerformanceSite_2_0-2.0.pdf
310032 RR_KeyPersonExpanded_2_0-2.0.pdf
310032 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310032 RR_Budget_1_4-1.4.pdf
310032 RR_SubawardBudget30_1_4-1.4.pdf
310032 PHS398_ModularBudget_1_2-1.2.pdf
310032 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
310032 RR_SF424_2_0-2.0.pdf
310032 PHS398_CoverPageSupplement_5_0-5.0.pdf
310032 RR_OtherProjectInfo_1_4-1.4.pdf
310032 PerformanceSite_2_0-2.0.pdf
310032 RR_KeyPersonExpanded_2_0-2.0.pdf
310032 PHS398_ResearchPlan_4_0-4.0.pdf
310032 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
310032 RR_Budget_1_4-1.4.pdf
310032 RR_SubawardBudget30_1_4-1.4.pdf
310032 PHS398_ModularBudget_1_2-1.2.pdf
310032 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
310032 RR_SF424_5_0-5.0.pdf
310032 PHS398_CoverPageSupplement_5_0-5.0.pdf
310032 RR_OtherProjectInfo_1_4-1.4.pdf
310032 PerformanceSite_4_0-4.0.pdf
310032 RR_KeyPersonExpanded_4_0-4.0.pdf
310032 PHS398_ResearchPlan_4_0-4.0.pdf
310032 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
310032 RR_Budget_3_0-3.0.pdf
310032 RR_SubawardBudget30_3_0-3.0.pdf
310032 PHS398_ModularBudget_1_2-1.2.pdf
310032 PHS_AssignmentRequestForm_3_0-3.0.pdf